Search results
Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia
Homenewshere.com· 6 days agoAfter AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased...
Blockbuster cancer drug Calquence hits primary endpoint in trial for first-line mantle cell lymphoma
Endpoints News· 5 days agoAstraZeneca is working on moving its BTK inhibitor Calquence into earlier stages of mantle cell...
Covishield Row: Indian Study Finds 55 Percent Recipients Suffered Minor Side Effects Of The Vaccine
MSN News· 2 days agoAn Indian study led by doctors from Assam Medical College Hospital in Dibrugarh has found that 55...
Hearing set to consider penalties for pharmaceutical company over Arkansas law | Arkansas Democrat...
Arkansas Democrat-Gazette· 3 days agoA battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up...
PRESS DIGEST-British Business - May 8
Reuters via Yahoo Finance· 12 minutes agoThe following are the top stories on the business pages of British newspapers. - Social media apps including TikTok and Instagram will be told to "tame aggressive algorithms" pushing harmful ...
ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant
Proactive Investors· 5 days agoANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive Andrew Newland joins Proactive's Stephen Gunnion...
E-Discovery Startup Fileread Hires Former AstraZeneca Head of Legal Services Josh Kreamer as GC |...
Law.com· 5 days agoE-discovery startup Fileread announced that it has hired Josh Kreamer, who most recently served as...
Q1 2024 FibroGen Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 14 hours agoI would like to remind you that remarks made on today's call include forward-looking statements about FibroGen. Such statements may include but are not limited to, our collaborations with < ...
Astrazeneca plc ADR (AZN) Has A Gold Mine On Its Hands – Stocks Register
Stocks Register· 6 days agoAstrazeneca plc ADR (NASDAQ:AZN) at last check was buoying at $76.06 on Thursday, May 02, with a fall of -0.46% from its closing price on previous day. Taking a look at stock ...
ANGLE teams up with AstraZeneca on a second assay
Proactive Investors· 5 days agoANGLE PLC (AIM:AGL, OTCQX:ANPCY), a leader in liquid biopsy technology, has signed a supplier agreement with AstraZeneca PLC (LSE:AZN) to develop an...
